vimarsana.com
Home
Live Updates
Metastatic crc
Live Breaking News & Updates on Metastatic crc
HER2-Amplified Colorectal Cancer: Clinical Trial Data
A focused discussion on HER2-amplified colorectal cancer and respective clinical trials that inform use of targeted agents in this setting.
Positive-colorectal-cancer
,
Novel-approaches
,
Amplified-colorectal-cancer
,
Clinical-trial-data
,
Colorectal-cancer
,
Metastatic-crc
,
Colon-cancer
,
Rectal-cancer
,
Ther2
,
Her2-positive
,
Tucatinib
Colorectal Cancer: Prevalence, Workup, and Molecular Subtypes
Opening their discussion on colorectal cancer, expert panelists consider its growing prevalence and highlight key molecular subtypes.
Positive-colorectal-cancer
,
Novel-approaches
,
Colorectal-cancer
,
Metastatic-crc
,
Colon-cancer
,
Rectal-cancer
,
Ther2
,
Her2-positive
,
Biomarker-testing
,
Molecular-testing
,
Molecular-lab-test
Colorectal Cancer: An Overview on Molecular Profiling
Shared insight on appropriate molecular lab testing options that should be explored following a diagnosis of colorectal cancer.
Positive-colorectal-cancer
,
Novel-approaches
,
Molecular-profiling
,
Colorectal-cancer
,
Metastatic-crc
,
Colon-cancer
,
Rectal-cancer
,
Ther2
,
Her2-positive
,
Biomarker-testing
,
Molecular-testing
Metastatic Colorectal Cancer: Future Directions in Care
Expert panelists identify key takeaways and share their excitement for future directions in the management of metastatic colorectal cancer.
Metastatic-colorectal-cancer-with
,
Positive-disease
,
Colorectal-cancer
,
Future-directions
,
Crc
,
Metastatic-crc
,
Dmcrc
,
Ngs
,
Next-generation-sequencing
,
Molecular-testing
,
Biomarker-testing
Novel Combination Strategies in mCRC: The STELLAR-303 and SUNLIGHT Trials
Before closing out their review of combination therapy in metastatic colorectal cancer, panelists discuss the STELLAR-303 and SUNLIGHT clinical trials.
Metastatic-colorectal-cancer-with
,
Positive-disease
,
Combination-strategies
,
Colorectal-cancer
,
Crc
,
Metastatic-crc
,
Dmcrc
,
Immunotherapy
,
Immune-checkpoint-inhibitors
,
Tki-therapy
,
Tyrosine-kinase-inhibitors
Combination IO/TKI Strategies in Metastatic Colorectal Cancer
A comprehensive review on combination strategies with immune checkpoint and tyrosine kinase inhibitors in patients with metastatic colorectal cancer.
Metastatic-colorectal-cancer-with
,
Positive-disease
,
Metastatic-colorectal-cancer
,
Colorectal-cancer
,
Crc
,
Metastatic-crc
,
Dmcrc
,
Immunotherapy
,
Immune-checkpoint-inhibitors
,
Tki-therapy
,
Tyrosine-kinase-inhibitors